MedTrace Logo

Calculating the LEmann IndeX Using InTEstiNal Ultrasound

NCT06647823 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2024-10-23

No results posted yet for this study

Summary

The goal of this clinical trial is to assess and quantitatively measure structural bowel damage in Crohn's disease (CD) with the Lèmann-Index (LI) for Intestinal Ultrasound (IUS). IUS is a non-invasive, easily repeated and well tolerated tool with no bowel preparations. With this study the investigators aim to show that IUS can replace Magnetic Resonance Enterography (MRE), which has been used to develop the original Lèmann-Index, to evaluate structural bowel damage.

For each patient, IUS and MRE (and Colonoscopy, if the colon is involved) will be performed within a two-month timeframe.

Conditions

  • Crohn Disease (CD)

Sponsors & Collaborators

  • The Leona M. and Harry B. Helmsley Charitable Trust

    collaborator OTHER

  • International Bowel Ultrasound Group e.V.

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-31
Primary Completion
2025-12-31
Completion
2026-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06647823 on ClinicalTrials.gov